Robert J Hancox1, Andrew R Gray2, Malcolm R Sears3, Richie Poulton4. 1. Department of Preventive & Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. Electronic address: bob.hancox@otago.ac.nz. 2. Department of Preventive & Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. 3. Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada. 4. Department of Psychology, University of Otago, Dunedin, New Zealand.
Abstract
BACKGROUND: Systemic inflammation is associated with impaired lung function in healthy adults as well as in patients with lung disease. The mechanism for this association is unknown and it is unclear if systemic inflammation leads to impaired lung function or if poor lung function leads to inflammation. We explored the temporal associations between blood C-reactive protein (CRP), fibrinogen, and white blood cells, and lung function in young adults. METHODS: Spirometry, plethysmography, and diffusion capacity were measured in a population-based cohort at ages 32 and 38 years. High-sensitivity CRP, fibrinogen, and white blood cells were measured at the same ages. RESULTS: Higher levels of CRP and, to a lesser extent, fibrinogen were associated with lower lung volumes in cross-sectional analyses at both ages 32 and 38 years. Higher CRP and fibrinogen at age 32 were associated with higher FEV1 and FEV1/FVC at age 38, but not other measures of lung function. Lower lung volumes (total lung capacity, functional residual capacity, and residual volume) but not airflow obstruction (FEV1/FVC) at age 32 were associated with higher CRP at age 38. Associations between age 32 lung function and fibrinogen at follow-up were weaker, but consistent. There were no longitudinal associations between white blood cells and lung function. CONCLUSIONS: We found no evidence that systemic inflammation causes a decline in lung function. However, lower lung volumes were associated with higher CRP and fibrinogen at follow-up indicating that pulmonary restriction may be a risk factor for systemic inflammation. The mechanism for this association remains unclear.
BACKGROUND:Systemic inflammation is associated with impaired lung function in healthy adults as well as in patients with lung disease. The mechanism for this association is unknown and it is unclear if systemic inflammation leads to impaired lung function or if poor lung function leads to inflammation. We explored the temporal associations between blood C-reactive protein (CRP), fibrinogen, and white blood cells, and lung function in young adults. METHODS: Spirometry, plethysmography, and diffusion capacity were measured in a population-based cohort at ages 32 and 38 years. High-sensitivity CRP, fibrinogen, and white blood cells were measured at the same ages. RESULTS: Higher levels of CRP and, to a lesser extent, fibrinogen were associated with lower lung volumes in cross-sectional analyses at both ages 32 and 38 years. Higher CRP and fibrinogen at age 32 were associated with higher FEV1 and FEV1/FVC at age 38, but not other measures of lung function. Lower lung volumes (total lung capacity, functional residual capacity, and residual volume) but not airflow obstruction (FEV1/FVC) at age 32 were associated with higher CRP at age 38. Associations between age 32 lung function and fibrinogen at follow-up were weaker, but consistent. There were no longitudinal associations between white blood cells and lung function. CONCLUSIONS: We found no evidence that systemic inflammation causes a decline in lung function. However, lower lung volumes were associated with higher CRP and fibrinogen at follow-up indicating that pulmonary restriction may be a risk factor for systemic inflammation. The mechanism for this association remains unclear.
Authors: J Wanger; J L Clausen; A Coates; O F Pedersen; V Brusasco; F Burgos; R Casaburi; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D Johnson; N Macintyre; R McKay; M R Miller; D Navajas; R Pellegrino; G Viegi Journal: Eur Respir J Date: 2005-09 Impact factor: 16.671
Authors: N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger Journal: Eur Respir J Date: 2005-10 Impact factor: 16.671
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Malcolm R Sears; Justina M Greene; Andrew R Willan; Elizabeth M Wiecek; D Robin Taylor; Erin M Flannery; Jan O Cowan; G Peter Herbison; Phil A Silva; Richie Poulton Journal: N Engl J Med Date: 2003-10-09 Impact factor: 91.245
Authors: Sheena E Martenies; Joshua W Schaeffer; Grant Erlandson; Mary Bradford; Jill A Poole; Ander Wilson; Zachary Weller; Stephen J Reynolds; Sheryl Magzamen Journal: J Occup Environ Med Date: 2020-06 Impact factor: 2.306
Authors: Jaime E Hart; Rebekah Goldstein; Palak Walia; Merilee Teylan; Antonio Lazzari; Carlos G Tun; Eric Garshick Journal: BMC Pulm Med Date: 2017-08-15 Impact factor: 3.317
Authors: Blanche C Ip; Nan Li; Medina Jackson-Browne; Melissa Eliot; Yingying Xu; Aimin Chen; Bruce P Lanphear; Adam J Spanier; Joseph M Braun Journal: J Dev Orig Health Dis Date: 2020-10-27 Impact factor: 2.401